Cybin Inc. (OTCMKTS:CLXPF - Get Free Report)'s share price rose 7.3% on Wednesday . The stock traded as high as $9.83 and last traded at $9.00. Approximately 1,153,557 shares changed hands during trading, an increase of 109% from the average daily volume of 551,962 shares. The stock had previously closed at $8.39.
Cybin Price Performance
The firm has a 50-day simple moving average of $7.60 and a two-hundred day simple moving average of $8.04. The company has a market cap of $1.18 billion and a PE ratio of -33.08.
About Cybin
(
Get Free Report)
Cybin Inc, a life sciences company, focuses on developing psychedelic therapeutics to treat various psychiatric and neurological conditions. The company operates through two segments, Serenity Life and Natures Journey. The Serenity Life segment engages in the research and development of pharmaceutical and nutraceutical psilocybin products.
Featured Stories
Before you consider Cybin, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cybin wasn't on the list.
While Cybin currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for August 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
